Featured Research

from universities, journals, and other organizations

Childhood virus may increase type 1 diabetes risk

Date:
March 31, 2014
Source:
University of Melbourne
Summary:
The most common cause of severe diarrhea in children, the rotavirus infection, has been shown to accelerate the development of type 1 diabetes in mice. The research found that it may be the "bystander effect" that causes the rotavirus infection to accelerate the onset of type 1 diabetes. The "bystander effect" suggests that the virus provokes a strong activation of the immune system, which then spills over, allowing the immune system to attack not only the viral intruder but some of the body's own cells, in this case the insulin-producing cells in the pancreas.

The most common cause of severe diarrhea in children, the rotavirus infection, has been shown to accelerate the development of type 1 diabetes in mice, according to new University of Melbourne research.

The study, published today in PLOS Pathogens, explored the ways the rotavirus infection contributes to autoimmune disease in mice, and researchers believe the breakthrough could be relevant to human infection with rotavirus.

The research found that it may be the "bystander effect" that causes the rotavirus infection to accelerate the onset of type 1 diabetes. The "bystander effect" suggests that the virus provokes a strong activation of the immune system, which then spills over, allowing the immune system to attack not only the viral intruder but some of the body's own cells, in this case the insulin-producing cells in the pancreas.

Lead researcher Associate Professor Barbara Coulson from the Peter Doherty Institute for Infection and Immunity said the research was the first to find that rotavirus activates this type of immune response in mice.

"This bystander mechanism provides a potential explanation for the acceleration of type 1 diabetes development by rotavirus infection in mice."

"It is possible that the same process could operate following human rotavirus infection, and lead to a more rapid progression of children towards type 1 diabetes. Further studies are needed to determine the relevance of our findings to humans," she said.

"Ultimately, this should help us understand the link between virus infection and the development of type 1 diabetes."

"Understanding how rotavirus affects human type 1 diabetes development is expected to facilitate the implementation of preventative treatment for children at risk this disease. For example, treatments that dampen down the particular type of immune response caused by rotavirus may be beneficial," she concluded.


Story Source:

The above story is based on materials provided by University of Melbourne. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jessica A. Pane, Nicole L. Webster, Barbara S. Coulson. Rotavirus Activates Lymphocytes from Non-Obese Diabetic Mice by Triggering Toll-Like Receptor 7 Signaling and Interferon Production in Plasmacytoid Dendritic Cells. PLoS Pathogens, 2014; 10 (3): e1003998 DOI: 10.1371/journal.ppat.1003998

Cite This Page:

University of Melbourne. "Childhood virus may increase type 1 diabetes risk." ScienceDaily. ScienceDaily, 31 March 2014. <www.sciencedaily.com/releases/2014/03/140331100407.htm>.
University of Melbourne. (2014, March 31). Childhood virus may increase type 1 diabetes risk. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/03/140331100407.htm
University of Melbourne. "Childhood virus may increase type 1 diabetes risk." ScienceDaily. www.sciencedaily.com/releases/2014/03/140331100407.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins